So we have the results which can be read in either of two ways.
It’s a bust. It doesn’t work. They’re stopping at end of Phase 2, they’ll try and recoup some losses by selling off their research to other companies. But if no-one takes it then ICX-TRC is dead. And even if they do, it’s disappointing which is why ICX wants to stop soon anyway.
It works. They see no commercial barriers to success. But despite this they don’t have the cash to take it to market, so are looking for partners, probably to inject cash. After all, from ICX’s point of view, 10% of billions is better than 100% of nothing and a bankrupt comapny.
And both of these can be inferred from the pdf we have seen.
However, I think we have to look between the lines here and recognise that if it had been good news they would not have put out a release that could have been misread as bad news by most people who read it. It wouldn’t have been so wishy-washy.
After all, who’d want to be responsible for crashing the company’s share price on the back of good news? Just because of a vague release.
The very fact that the release is vague and can be read in opposing ways says everything we need to know…
Id love to agree with that, but I have one problem…
where are the pictures? They said all five men with pre-stimulation had SIGNIFIGANT and VISIBLE regrowth. HT docs put up tons of pictures. HM cant show us even one pic of the best responders treatment area? Not one?
Where are the stats? What percentage did hair growth increase? They want to sell it for as much as possible, so why wouldn’t they put that in there. Nobody is going to buy it without seeing it…I just cant see results being very good if they had a “decent” result but chose to not go into detail about it. Even a decent result would mean someone could get two rounds of treatment and have a chance at a nice result. I think they are only getting “some” regrowth, about like one might get on finasteride, and probably very little in the front.
Bald heads are NOT “TREATMENT AREAS”, they are entire bald heads, theoretically one is supposed to be able to shoot up the entire scalp with this stuff and hair grow everywhere. They damn well know their release was very evasive, and I guarantee you they have looked at this website today and note the dissapointment. If I’d seen a good couple of pics, I’d have gotten on the phone and put a few thousand for shares myself…but not now.
“Oh, yeah, it works, but consistency is not yet good enough for commercial release, blah blah…”
“It works, but our priority is now to help those poor burn victims, blah blah blah.”
ok, I am going to stop my sacasm for now.
Lets wait for Paul Kemp’s explanations… and then we will see…
They damn well know their release was
» very evasive, and I guarantee you they have looked at this website today
» and note the disappointment. If I’d seen a good couple of pics, I’d have
» gotten on the phone and put a few thousand for shares myself…but
» not now.
Hi Benji,
That was my whole point. The fact that the press release is evasive says all we need to know. It’s not good news.
If it WAS good news it would be a lot clearer, and as you say, they’d be trumpeting their results more - including pictures and hair counts etc.
But no-one is going to put out an unclear press release that could affect the share price, when they have groundbreakingly good news.
» So we have the results which can be read in either of two ways.
»
» 1) It’s a bust. It doesn’t work. They’re stopping at end of Phase 2,
» they’ll try and recoup some losses by selling off their research to other
» companies. But if no-one takes it then ICX-TRC is dead. And even if they
» do, it’s disappointing which is why ICX wants to stop soon anyway.
»
» 2) It works. They see no commercial barriers to success. But despite
» this they don’t have the cash to take it to market, so are looking for
» partners, probably to inject cash. After all, from ICX’s point of view,
» 10% of billions is better than 100% of nothing and a bankrupt comapny.
»
or maybe :
It’s still being tested and isn’t close to ready yet, so no conclusion can be drawn at that point. They’re now focusing on the release of Vavelta to get cash as soon as possible and will keep doing more trials on TRC so we can be fixed later, possibly in 2009.
» So we have the results which can be read in either of two ways.
»
» 1) It’s a bust. It doesn’t work. They’re stopping at end of Phase 2,
» they’ll try and recoup some losses by selling off their research to other
» companies. But if no-one takes it then ICX-TRC is dead. And even if they
» do, it’s disappointing which is why ICX wants to stop soon anyway.
»
» 2) It works. They see no commercial barriers to success. But despite
» this they don’t have the cash to take it to market, so are looking for
» partners, probably to inject cash. After all, from ICX’s point of view,
» 10% of billions is better than 100% of nothing and a bankrupt comapny.
»
» And both of these can be inferred from the pdf we have seen.
»
» However, I think we have to look between the lines here and recognise that
» if it had been good news they would not have put out a release that could
» have been misread as bad news by most people who read it. It wouldn’t have
» been so wishy-washy.
»
» After all, who’d want to be responsible for crashing the company’s share
» price on the back of good news? Just because of a vague release.
»
» The very fact that the release is vague and can be read in opposing ways
» says everything we need to know…
This is an advertising site for paid
advertisers to showcase successful hair restoration results only. It is not the
mandate of this site to engage in the discussion of failed, unsuccessful
procedures, lawsuits, litigations, refunds or complaint cases. Surgical hair
restoration procedures carry risks. Please do thorough research, consult your
own physician and investigate a doctor's background carefully before making a
decision. By proceeding to use our site, you agree to abide by our Terms of Use & Privacy Policy at http://hairsite.com/terms-of-use/ where you can also find a list of HairSite's sponsoring physicians.
